AJMC November 21, 2024
Mary Caffrey

Key Takeaways

  • Precision medicine has replaced aggressive drug therapies, improving cancer outcomes and patient quality of life.
  • Ageism in oncology leads to underrepresentation of older patients in clinical trials and exclusion from intensive therapies.
  • City of Hope integrates supportive and integrative oncology, focusing on holistic care to enhance patient well-being.
  • Expanding access to comprehensive assessments and innovative therapies aims to democratize cancer care.
  • Maintaining consistent, high-quality care across multiple sites involves clinical trials, genomic testing, and standardized pathways.

Institute for Value-Based Medicine event with City of Hope.

To hear Joseph Alvarnas, MD, tell it, the fight against cancer was once seen as a mission to create increasingly powerful drugs—as much as the human body could handle—and pummel the...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Patient / Consumer, Payment Models, Pharma / Biotech, Precision Medicine, Provider, Value Based
Daniel Kraft: “The future of healthcare depends on our mindset”
What Home-Based Care Consumers Really Want
STAT+: 9 influencers shaping health information online, for better or worse
Fortifying Medicaid Managed Care for Postpartum Enrollees: The Clearest Path to Improving Maternal Health
Serious Illness Care Runs on Caregivers — It’s Time to Act Like It

Share Article